Harmony Biosciences Holdings (HRMY)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	128,853	181,468	34,597	-36,944
Revenue	US$ in thousands	548,499	419,060	255,101	134,691
Net profit margin		23.49%	43.30%	13.56%	-27.43%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $128,853K ÷ $548,499K
= 23.49%

The net profit margin of Harmony Biosciences Holdings Inc has shown significant variability over the past four years. In 2023, the net profit margin stood at 22.14%, reflecting a decrease from the previous year's robust margin of 41.44%. Despite this decline, the company still maintained a healthy level of profitability relative to its revenue for the year.

In contrast, the net profit margin for 2021 was 11.33%, indicating a modest level of profitability compared to the preceding year. However, the most notable observation is the significant negative net profit margin of -39.97% in 2020, which suggests that the company incurred a loss relative to its revenue during that period.

Overall, the fluctuation in Harmony Biosciences Holdings Inc's net profit margin highlights the volatility in its profitability performance over the analyzed period. To further assess the company's financial health and stability, it would be beneficial to consider additional financial ratios and contextual information to gain a comprehensive understanding of its overall performance and prospects.